openPR Logo
Press release

UK Preventive Inhaler Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

08-25-2021 01:01 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

UK preventive inhaler market is anticipated to grow at a substantial growth of around 1.5% during the forecast period. Preventive inhalers are most probably the most important asthma medication as they treat the inflammation inside the airways and decrease the possibility of an asthma exacerbation. As the prevalence of asthma and other diseases increases across UK, the demand for preventive inhalers is also expected to increase for treatment purposes. As per International Monetary Fund GDP of the country was $2.9 trillion in 2017. UK comprises of England, Scotland, Wales and Northern Ireland. Total population of the country in 2017 was 65 million, out of which about 18% are of geriatric population. Mortalities related to asthma and COPD are high in UK and due to these a significant investment by government and people can be forecast in the near future.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/uk-preventive-inhaler-market

The UK preventive inhaler market is segmented on the basis of device type, application, and end-user. On the basis of device type, the market is sub-segmented into metered dosed inhaler and dry powdered inhaler. The dry powder inhaler is estimated to have largest market share in the UK preventive inhaler market due to providing easy inhalation solution. Whereas, the market for metered dose inhaler is estimated to be the fastest growing at a CAGR during the forecast period owing to innovations and collaborations by the companies for the development of metered dosed inhaler. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/uk-preventive-inhaler-market

Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing preventive inhalers to cater to a wide range of customers within the region and across the globe. The major players of the UK preventive inhaler market include Boehringer Ingelheim International GmbH, AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Teva Pharmaceuticals Industries Ltd., Koninklijke Philips N.V., and Bespak. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.

Market Segmentation
UK Preventive Inhaler Market by Device Type
• Metered Dose Inhaler
• Dry Powder Inhaler

UK Preventive Inhaler Market by Application
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

UK Preventive Inhaler Market by End-User
• Homecare
• Hospitals and Clinics

Company Profiles
• 3M Co.
• Acorda Therapeutics, Inc.
• Adamis Pharmaceuticals Corp.
• Adherium Ltd.
• AstraZeneca PLC
• Bespak
• Boehringer Ingelheim International GmbH
• Chiesi Farmaceutici S.P.A.
• GF Health
• GlaxoSmithKline PLC
• H&T Presspart Manufacturing Ltd.
• Koninklijke Philips N.V.
• Novartis AG
• Omron Healthcare Inc.
• ResMed Corp.
• Pulmatrix Inc.
• Savara, Inc.
• Teicos Pharma Ltd.
• Teva Pharmaceuticals Industries Ltd.
• Vitalograph Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/uk-preventive-inhaler-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release UK Preventive Inhaler Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027 here

News-ID: 2367109 • Views:

More Releases from Orion Market Research

Terahertz Technology Market Set to Witness Significant Growth by 2032 | TOPTICA Photonics AG, Advantest Corporation, Batop GmbH
Terahertz Technology Market Set to Witness Significant Growth by 2032 | TOPTICA …
The Terahertz Technology Market was valued at approximately USD 1.09 billion in 2024 and is projected to reach USD 4.08 billion by 2032, reflecting a compound annual growth rate (CAGR) of 18.1% from 2025 to 2032. Terahertz Technology Market Overview Terahertz (THz) technology operates in the electromagnetic spectrum between microwave and infrared waves, encompassing frequencies from 0.1 to 10 THz. This technology is gaining prominence due to its non-ionizing radiation, enabling
Specialty Tapes Market Set to Witness Significant Growth by 2032 | Avery Dennison Corporation, Scapa Group Plc, Intertape Polymer Group
Specialty Tapes Market Set to Witness Significant Growth by 2032 | Avery Denniso …
The global Specialty Tapes Market was valued at approximately USD 55.39 billion in 2023 and is projected to reach USD 96.3 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.3% from 2024 to 2032. Specialty Tapes Market Overview The Specialty Tapes Market encompasses a diverse range of adhesive products tailored for specific applications across various industries. These tapes are characterized by their unique properties, such as high temperature
Safety Helmets Market Set to Witness Significant Growth by 2033 | MSA Safety, Uvex Safety Group, Delta Plus Group, Bullard, Schuberth GmbH
Safety Helmets Market Set to Witness Significant Growth by 2033 | MSA Safety, Uv …
The global Safety Helmets Market was valued at approximately USD 5.01 billion in 2024, and it is expected to reach around USD 9.76 billion by 2033, growing at a *compound annual growth rate (CAGR) of about 7.7% from 2025 to 2033. Safety Helmets Market Overview The Safety Helmets Market is gaining momentum as industries like construction, manufacturing, mining, and infrastructure increasingly emphasize worker safety and regulatory compliance. Safety helmets-designed to protect against
Sales Performance Management Market Gaining Momentum by 2033 | Xactly Corporation, Anaplan Inc., IBM Corporation, Varicent Software Inc.
Sales Performance Management Market Gaining Momentum by 2033 | Xactly Corporatio …
The global Sales Performance Management market was valued at approximately USD 5.62 billion in 2024 and is projected to grow to about USD 18.22 billion by 2033, with a compound annual growth rate (CAGR) of approximately 13.27% between 2025 and 2033. Sales Performance Management Market Overview Sales Performance Management integrates tools and processes designed to boost sales productivity, optimize incentive structures, and align field sales efforts with business goals. Today's market is

All 5 Releases


More Releases for Inhaler

12-09-2024 | Health & Medicine
Getnews
Z!NGHA Introduces Dual-Chamber Aromatherapy Nasal Inhaler
Image: https://www.getnews.info/uploads/e696f4bdf98524eaf4f4f4bc89f2369f.jpg Miami, FL - December 09, 2024 - Z!NGHA, a new player in the wellness space, is thrilled to announce the launch of its flagship product, the Z!NGHA Double Nasal Inhaler, an innovation that combines the therapeutic benefits of aromatherapy and essential oils with the on-the-go convenience of a dual-chamber nasal inhaler. Unlike the industry standard single chamber nasal inahlers, Z!ngha offers simultaneous inhalation through both nostrils, redefining aromatherapy for
Asthma Inhaler Device Market By Type (Metered-dose inhaler, MDI with a spacer, D …
The Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19677.54 million by the end of 2022-2030. The research report on the market for asthma inhaler devices offers analysis and insights into the numerous aspects that are anticipated to be present over the course of the forecast period as well as
Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma
Oxygen Inhaler Market Size, Share, Growth & Forecast 2026
Global Oxygen Inhaler Market report focuses on Oxygen Inhaler volume and value at global level, regional level and company level. From a global perspective, this report represents the overall Oxygen Inhaler market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and